Study recommends extending HPV vaccine to adolescent boys

A study by Porto’s FMUP (university medicine faculty) has concluded that vaccination against the Human Papilloma virus (that can cause vaginal/ uterine cancers) should be extended to adolescent boys and youths up to the age of 26. The idea is to innoculate young males before they start their sex life. With this widening of the vaccination pool (up till now it is a vaccine offered by the State health service to pre-pubescent girls), specialists believe it could reduce the risk of infection by the virus, and the speading of all its associated diseases. The study was financed by the 2020 Horizon EN programme.